File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A metabolomics-based strategy for the quality control of traditional chinese medicine: Shengmai injection as a case study

TitleA metabolomics-based strategy for the quality control of traditional chinese medicine: Shengmai injection as a case study
Authors
Issue Date2013
Citation
Evidence-based Complementary and Alternative Medicine, 2013, v. 2013, article no. 836179 How to Cite?
AbstractQuality control of traditional Chinese medicines (TCMs) used clinically is becoming a challenge and has limited the development of TCM due to the high variability in concentration levels of active ingredients and markers as well as the lack of well-established criteria. Using Shengmai injection, which is a well-established TCM, as an example, we developed an integrated profiling approach that simultaneously captures the entire spectrum of ingredients and quantitatively determines the levels of seven key ingredients in the TCM product. A multivariate statistical model was constructed to establish a "seven-marker-" based quality standard that qualified the majority of samples in this study. This newly developed strategy showed that a panel of key ingredients or markers in the TCM product were relatively consistent within a statistically acceptable range. Therefore, this metabolomics-based approach will complement the current quality control standard using the concentration of several key ingredients or their total content and help improve the consistency and clinic efficacy of TCM products. © 2013 Xiaodong Li et al.
Persistent Identifierhttp://hdl.handle.net/10722/342735
ISSN
2021 Impact Factor: 2.650
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLi, Xiaodong-
dc.contributor.authorChen, Huiyuan-
dc.contributor.authorJia, Wei-
dc.contributor.authorXie, Guoxiang-
dc.date.accessioned2024-04-17T07:05:53Z-
dc.date.available2024-04-17T07:05:53Z-
dc.date.issued2013-
dc.identifier.citationEvidence-based Complementary and Alternative Medicine, 2013, v. 2013, article no. 836179-
dc.identifier.issn1741-427X-
dc.identifier.urihttp://hdl.handle.net/10722/342735-
dc.description.abstractQuality control of traditional Chinese medicines (TCMs) used clinically is becoming a challenge and has limited the development of TCM due to the high variability in concentration levels of active ingredients and markers as well as the lack of well-established criteria. Using Shengmai injection, which is a well-established TCM, as an example, we developed an integrated profiling approach that simultaneously captures the entire spectrum of ingredients and quantitatively determines the levels of seven key ingredients in the TCM product. A multivariate statistical model was constructed to establish a "seven-marker-" based quality standard that qualified the majority of samples in this study. This newly developed strategy showed that a panel of key ingredients or markers in the TCM product were relatively consistent within a statistically acceptable range. Therefore, this metabolomics-based approach will complement the current quality control standard using the concentration of several key ingredients or their total content and help improve the consistency and clinic efficacy of TCM products. © 2013 Xiaodong Li et al.-
dc.languageeng-
dc.relation.ispartofEvidence-based Complementary and Alternative Medicine-
dc.titleA metabolomics-based strategy for the quality control of traditional chinese medicine: Shengmai injection as a case study-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1155/2013/836179-
dc.identifier.scopuseid_2-s2.0-84874524154-
dc.identifier.volume2013-
dc.identifier.spagearticle no. 836179-
dc.identifier.epagearticle no. 836179-
dc.identifier.eissn1741-4288-
dc.identifier.isiWOS:000314416100001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats